Bicalutamide 50 mg Tablet (Generic)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bicalutamide 50 mg Tablet (Generic), covering 2017-03-28 to 2017-03-28. Get the full timeline:
Most recent: Clinical Trial Update: Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions [Phase 1]